FEATURES OF MULTIPARAMETRIC MRI STUDY IN PROSTATE CANCER
Authors
Maksudov M.F., Khaidarov U.O.
Share
Annotation
Prostate cancer (PCa) is the most common cancer among the male population of the world, accounting for 22.7% of all diagnosed malignant diseases (excluding non-melanoma skin cancer), and is the second leading cause of death among cancer patients [2]. MRI is included in the list of mandatory diagnostic studies of PCa [4]. In recent years, a trend has been identified that demonstrates a certain value of traditional diffusion-weighted imaging ( DWI ) with T2 - weighted imaging (T2 w ) in magnetic resonance imaging (MRI), which is a key component of multiparametric MRI (mpMRI) in screening for prostate diseases, including PCa [ 1 , 3].
Authors
Maksudov M.F., Khaidarov U.O.
Share
References:
1. Abreu-Gomez J, Lim C, Haider MA. Contemporary Approach to Prostate Imaging and Data Reporting System Score 3 Lessons. Radiol Clin North Am. 2024 Jan;62(1):37-51. doi: 10.1016/j.rcl.2023.06.008
2. Robert-Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V.Hrsg. Krebs in Germany für 2015/2016. Berlin, 2019; 12. Aufl. doi:10.25646/5977
3. Spilseth B, Margolis DJA, Gupta RT, Chang SD. Interpretation of Prostate Magnetic Resonance Imaging Using Prostate Imaging and Data Reporting System Version 2.1: A Primer. Radiol Clin North Am. 2024 Jan;62(1):17-36. doi: 10.1016/j.rcl.2023.06.007
4. Wei JT, Barocas D, Carlsson S, Coakley F, Eggener S, Etzioni R, Fine SW, Han M, Kim SK, Kirkby E, Konety BR, Miner M, Moses K, Nissenberg MG, Pinto PA, Salami SS, Souter L , Thompson IM, Lin DW. Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy. J Urol. 2023 Jul;210(1):54-63. doi: 10.1097/JU.0000000000003492
Other articles of the issue
